Hemostatic Powder Cylindrical Particles Gas Exchange

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hemostatic powders have insufficient absorption and retention capacity for biological fluids, forming a paste that limits their effectiveness and gas exchange at wound sites.

Innovation Solution

A powder composed of cylindrical particles made from hemostatic fibers, preferably calcium alginate, which forms a three-dimensional structure for enhanced absorption and retention, ensuring gas exchange and tissue regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If spherical hemostatic powder particles are used, then the powder can be easily applied to wounds, but the absorption and retention capacity for biological fluids is insufficient and the particles form a paste that limits gas exchange

Engineering Contradiction:
Improveabsorption and retention capacityVSAvoidpaste formation limiting gas exchange
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The invention divides the hemostatic material into cylindrical particles with specific dimensions (length 20-2000 μm, diameter 5-50 μm) rather than using spherical particles. This segmentation into elongated shapes creates inter-particle voids that maintain porosity and prevent paste formation, allowing gas exchange while increasing absorption capacity through greater surface area and capillary action along the cylindrical surfaces.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The cylindrical particle structure inherently creates a porous framework when applied to wounds. The elongated shape and specific size range maintain inter-particle spaces that preserve gas permeability while the porous structure of individual cylindrical particles provides capillary channels for fluid absorption and retention, solving the contradiction between absorption capacity and gas exchange.

Inventive Principle:
Principle #31Porous materials

2Quantity of substance

If the powder forms a paste to increase absorption, then absorption capacity improves, but gas exchange at the wound site is limited

Engineering Contradiction:
Improveabsorption capacityVSAvoidgas exchange capability
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The invention transitions from spherical (0-dimensional surface) to cylindrical (1-dimensional extended surface) particles, adding a dimensional aspect that creates vertical channels for gas exchange while maintaining horizontal absorption capacity. The cylindrical geometry provides both absorption surfaces and gas permeation pathways simultaneously, resolving the contradiction between absorption and gas exchange.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Ease of operation

If particle diameter is less than 5 μm, then the powder can penetrate tissue effectively, but aerosol formation causes respiratory toxicity

Engineering Contradiction:
Improvetissue penetration capabilityVSAvoidrespiratory toxicity from aerosol
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The invention specifies a particle diameter range of 5-50 μm, changing the size parameter from sub-5 μm to a controlled range that prevents aerosol formation (particles larger than 5 μm do not remain suspended as aerosols) while still allowing tissue penetration through the lower end of the range (5-30 μm preferred). This parameter optimization eliminates respiratory toxicity while maintaining therapeutic effectiveness.

Inventive Principle:
Principle #35Parameter changes

4Object-affected harmful factors

If particle diameter is greater than 50 μm, then respiratory toxicity is avoided, but the capacity for flow and adhesion to tissues is limited

Engineering Contradiction:
Improverespiratory toxicity preventionVSAvoidadhesion to tissues
Core Design Contradiction:
Object-affected harmful factorsVSStrength

Solution Approach 1:

The invention defines an optimal particle diameter range of 5-50 μm with a preferred range of 10-30 μm, changing the size parameter to balance adhesion and safety. Particles in this range are small enough to adhere to tissue surfaces through capillary forces and van der Waals forces, yet large enough to avoid aerosol formation and respiratory toxicity, achieving both adhesion and safety simultaneously.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The cylindrical particle structure significantly increases absorption and retention capabilities while maintaining optimal gas exchange, facilitating wound healing and tissue repair.

Implementation Method 1

the particles of the powder of the invention form a three-dimensional structure distributing them geometrically in a ventilated manner on the surface of the wound. Thus, thanks to the particular cylindrical shape of the particles of the powder, its power of absorption and retention is notably increased

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Implementation Method 2

by the gelation of its structure in contact with blood or exudates from an oozing wound, calcium alginate creates a kind of artificial skin which protects the wound

Methodology Applied
Scientific EffectGelation: Gel

Implementation Method 3

the particles of the powder of the invention form a three-dimensional structure distributing them geometrically in a ventilated manner on the surface of the wound, ensuring gas exchange with the wound

Methodology Applied
Scientific EffectPorosity: Porosity

Implementation Method 4

by the gelation of its structure in contact with blood or exudates from an oozing wound, calcium alginate creates a kind of artificial skin which protects the wound from external shocks and thermal variations

Methodology Applied
Scientific EffectGelation: Gel

Data Source

PatentEP2836243B1Powder forming a dressing and corresponding absorbing material
Publication Date: 2016.02.17 LES LAB BROTHIER
  • EP2836243B1 patent drawingFigure 1

AI summary

The invention relates to a powder (14) forming a dressing, which is characterized in that it is formed by a plurality of cylindrical particles that are produced from fibers. It is preferable for the particles to be hemostatic calcium alginate fibers, the length of which is between 20 mum and 2 mm and the diameter of which is between 5 mum and 50 mum.